Literature DB >> 2160235

Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues.

K J Murray1, P J England, J A Lynham, D Mills, C Schmitz-Peiffer, M L Reeves.   

Abstract

1. The cyclic AMP-dependent protein kinase activity-ratio assay was investigated by comparing histone and a synthetic peptide, malantide [Malencik & Anderson (1983) Anal. Biochem. 132, 32-40], as substrates. 2. In several tissues the activity ratio was higher when assayed with histone as the substrate; this result was obtained in control tissues and also in those incubated with agents known to increase cyclic AMP. The effect of these agents to increase the activity ratio was more clearly demonstrated with malantide. 3. The higher activity ratios observed with histone are due to: (a) measurement of phosphorylation not catalysed by cyclic AMP-dependent protein kinase; (b) activation of cyclic AMP-dependent protein kinase by histone during the assay. 4. When tissues were homogenized in buffers without NACl, lower activity ratios were found, owing to the catalytic subunit being artifactually removed from the supernatant. 5. We conclude that the measured activity ratio more faithfully reflects that in the tissue when NaCl is included in the homogenization buffer and malantide is used in the assay. This was confirmed in experiments where cyclic AMP-dependent protein kinase was added to the tissue before homogenization, and no dissociation of the exogenous enzyme was observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160235      PMCID: PMC1131354          DOI: 10.1042/bj2670703

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  On the question of translocation of heart cAMP-dependent protein kinase.

Authors:  S L Keely; J D Corbin; C R Park
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Studies on the properties and mode of action of the purified regulatory subunit of bovine heart adenosine 3':5'-monophosphate-dependent protein kinase.

Authors:  J D Corbin; P H Sugden; L West; D A Flockhart; T M Lincoln; D McCarthy
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Studies on the alpha-andrenergic activation of hepatic glucose output. II. Investigation of the roles of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in the actions of phenylephrine in isolated hepatocytes.

Authors:  A D Cherrington; F D Assimacopoulos; S C Harper; J D Corbin; C R Park; J H Exton
Journal:  J Biol Chem       Date:  1976-09-10       Impact factor: 5.157

5.  Dissociation and activation of adenosine 3',5'-monophosphate-dependent and guanosine 3',5'-monophosphate-dependent protein kinases by cyclic nucleotides and by substrate proteins.

Authors:  E Miyamoto; G L Petzold; J F Kuo; P Greengard
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

6.  Assay of cyclic AMP-dependent protein kinases.

Authors:  J D Corbin; E M Reimann
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

7.  Kinetic parameters of transport of 3-O-methylglucose and glucose in adipocytes.

Authors:  R R Whitesell; J Gliemann
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

8.  Evaluation of kemptide, a synthetic serine-containing heptapeptide, as a phosphate acceptor for the estimation of cyclic AMP-dependent protein kinase activity in respiratory tissues.

Authors:  M A Giembycz; J Diamond
Journal:  Biochem Pharmacol       Date:  1990-01-15       Impact factor: 5.858

9.  The substrate specificity of adenosine 3':5'-cyclic monophosphate-dependent protein kinase of rabbit skeletal muscle.

Authors:  S J Yeaman; P Cohen; D C Watson; G H Dixon
Journal:  Biochem J       Date:  1977-02-15       Impact factor: 3.857

10.  Studies on the phosphorylation of the inhibitory subunit of troponin during modification of contraction in perfused rat heart.

Authors:  P J England
Journal:  Biochem J       Date:  1976-11-15       Impact factor: 3.857

View more
  13 in total

1.  Engineering a bioluminescent indicator for cyclic AMP-dependent protein kinase.

Authors:  G B Sala-Newby; A K Campbell
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

2.  Effects of lactation on the signal transduction systems regulating lipolysis in sheep subcutaneous and omental adipose tissue.

Authors:  R G Vernon; R Doris; E Finley; M D Houslay; E Kilgour; S Lindsay-Watt
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

3.  A rat skeletal muscle cell line (L6) expresses specific adrenomedullin binding sites but activates adenylate cyclase via calcitonin gene-related peptide receptors.

Authors:  H A Coppock; A A Owji; S R Bloom; D M Smith
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

4.  Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.

Authors:  J E Merritt; T J Hallam; A M Brown; I Boyfield; D G Cooper; D M Hickey; A A Jaxa-Chamiec; A J Kaumann; M Keen; E Kelly
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

5.  Novel bradykinin signalling events in PC-12 cells: stimulation of the cAMP pathway leads to cAMP-mediated translocation of protein kinase Cepsilon.

Authors:  A Graness; A Adomeit; B Ludwig; W D Müller; R Kaufmann; C Liebmann
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

6.  A 5-HT4-like receptor in human right atrium.

Authors:  A J Kaumann; L Sanders; A M Brown; K J Murray; M J Brown
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

7.  The effect of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function.

Authors:  K J Murray; R J Eden; J S Dolan; D C Grimsditch; C A Stutchbury; B Patel; A Knowles; A Worby; J A Lynham; W J Coates
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

8.  Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium.

Authors:  A J Sandilands; K M O'Shaughnessy; M J Brown
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

9.  Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure.

Authors:  Trond Brattelid; Eirik Qvigstad; James A Lynham; Peter Molenaar; Halfdan Aass; Odd Geiran; Tor Skomedal; Jan-Bjørn Osnes; Finn Olav Levy; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-07       Impact factor: 3.000

10.  Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain.

Authors:  Zhihou Liang; Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  J Neurochem       Date:  2007-10-01       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.